THE CRITICALLY ILL OLDER PERSON WITH: SEPTIC SHOCK

Similar documents
Sepsis Management: Past, Present, and Future

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

INTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017

The syndrome formerly known as. Severe Sepsis. James Rooks MD. Coordinator of critical care education OU College of Medicine, Tulsa

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

towards early goal directed therapy

Controversies in Hospital Medicine: Critical Care. Vasopressors, Steroids, and Insulin Therapy

What is the Role of Albumin in Sepsis? An Evidenced Based Affair. Justin Belsky MD PGY3 2/6/14

OHSU. Update in Sepsis

Sepsis and Hemodynamic Support in September 15, 2017 Carleen Risaliti

Sepsis Management Update 2014

Sepsis: Identification and Management in an Acute Care Setting

John Park, MD Assistant Professor of Medicine

The Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP

Top Sepsis Studies

Subclinical Problems in the ICU:

Vasopressors in Septic Shock. Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada

9/25/2017. Nothing to disclose

Nothing to disclose 9/25/2017

Early-goal-directed therapy and protocolised treatment in septic shock

Updates in Critical Care Sepsis, Fluids, Epi and Long-Term Outcomes

CORTICOSTEROID USE IN SEPTIC SHOCK THE ONGOING DEBATE DIEM HO, PHARMD PGY1 PHARMACY RESIDENT VALLEY BAPTIST MEDICAL CENTER BROWNSVILLE

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy

Advancements in Sepsis

Approach to Severe Sepsis. Jan Hau Lee, MBBS, MRCPCH. MCI Children s Intensive Care Unit KK Women s and Children's Hospital, Singapore

Steroid in Paediatric Sepsis. Dr Pon Kah Min Hospital Pulau Pinang

Initial Resuscitation of Sepsis & Septic Shock

Early Goal-Directed Therapy

Fluid Treatments in Sepsis: Meta-Analyses

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated

Surviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM

BC Sepsis Network Emergency Department Sepsis Guidelines

Sepsis. From EMS to ER to ICU. What we need to be doing

Presented by: Indah Dwi Pratiwi

Objectives. Outline. Sepsis Incidence and Outcomes. Definitions

Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI)

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

SEPSIS 2015 DISCLOSURES FINANCIAL DISCLOSURES 9/1/2015. William M. Johnson, MD Nebraska Pulmonary Specialties. William Johnson

Tailored Volume Resuscitation in the Critically Ill is Achievable. Objectives. Clinical Case 2/16/2018

Staging Sepsis for the Emergency Department: Physician

4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures

Albumina nel paziente critico. Savona 18 aprile 2007

Modern fluid therapy. Anders Perner. Dept of Intensive Care, Rigshospitalet, University of Copenhagen

Sepsis Learning Collaborative: Sepsis New Definitions

Looking for sepsis. Sepsis: Update. Prevalence of High Profile Dzs. Screening and risk stratification. Mortality of High Profile Diseases

Why Focus on Sepsis?

Sepsis Story At Intermountain Healthcare Intensive Medicine Clinical Program

Why does it matter? Sepsis

Resuscitation Symposium Resuscitation Literature Update. Abdullah Al Reesi, MD, MSc, FACEP, FRCPC Sr. Consultant and HoD SQUH

JOURNAL CLUB: THE FLUIDS DEBATE. Veronica Ueckermann

Objectives. Pathophysiology of Steroids. Question 1. Pathophysiology 3/1/2010. Steroids in Septic Shock: An Update

6/5/2014. Sepsis Management and Hemodynamics. 2004: International group of experts,

Surviving Sepsis Campaign

The Use of Metabolic Resuscitation in Sepsis

SEPSIS: IT ALL BEGINS WITH INFECTION. Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft.

Sepsis Bundle Project (SEP) Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: April 2015 Most recent Revision: December 2018

Early Goal Directed Therapy in 2015: What Did the Big Trials Teach us?

Printed copies of this document may not be up to date, obtain the most recent version from

Fluids in Sepsis Less is more. Dr Anand Senthi Joondalup Health Campus ED MBBS, MAppFin, GradCertPubHlth,

Sepsis and septic shock: can we win the battle against this hidden crisis?

Steroids for ARDS. Clinical Problem. Management

Update in Critical Care Medicine

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS

Should we use steroids in sepsis? J.G. van der Hoeven

Sepsis Early Recognition and Management. Therese Hughes, PhD, MPA, RN

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program

Diagnosis and Management of Sepsis and Septic Shock. Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.

Year in Review 2014: Critical Care Medicine

Early goal-directed therapy Where to from here? Rinaldo Bellomo ANZIC Research Centre Melbourne, Australia

New Strategies in the Management of Patients with Severe Sepsis

Welcome! While we wait, please open PollEv.com/jhhicu012

Managing Patients with Sepsis

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

Novel Sepsis Therapies

Sepsis: What Is It Really?

6-horas 24 horas Coleta de lactato Hemoculturas. Corticosteróides. Controle glicêmico. Fluidos/vasopressores. Otimização de SvO 2

Septic AKI in ICU patients

Nurse Driven Fluid Optimization Using Dynamic Assessments

Redefining sepsis and sepsis treatment

What the ED clinician needs to know about SEPSIS - 3. Anna Morgan Consultant EM Barts Health

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand

Vasopressors for shock

MAKING SENSE OF IT ALL AUGUST 17

Albumin: rationale, use and evidence

Corticosteroids in Severe CAP. Mervyn Mer Department of Medicine & ICU Johannesburg Hospital University of the Witwatersrand

Diagnosis: Allergies:

Updates in Sepsis 2017

Sepsi: nuove definizioni, approccio diagnostico e terapia

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Sepsis: Update on Diagnosis, Evaluation and Management

Supplementary Appendix

VOLUME RESPONSIVENESS IS DIFFERENT FROM NEED FOR FLUIDS BLOOD PRESSURE TARGETS IN SEPSIS

SEPSIS-3: THE NEW DEFINITIONS

Transcription:

THE CRITICALLY ILL OLDER PERSON WITH: SEPTIC SHOCK

Older people carry the burden of sepsis

Older people carry the burden of sepsis Immunosenescence Co-morbidity Endothelial / mucosal atrophy Dependence hospital, RACF Pre-admission functional decline Diagnostic challenges

SEPSIS TRIALS IN THE ELDERLY

SEPSIS TRIALS IN THE ELDERLY 142 sepsis trials including adults >65 years Average cohort age <65 years in 87% trials Single trial (0.7%) focussed on adults >65

There are few data specifically examining septic shock in the elderly Most study cohorts are not representative of elderly patients A small minority of studies conducted age-based subgroup analyses. Aspect of sepsis Trial Age Age-based subgp analysis? Early Goal-directed therapy Rivers 64/67 No ProCESS (USA) 62 No ARISE (ANZ) 63 No ProMISe (UK) 64 Yes Antibiotics trial PHANTASi (pre-hospital ABs) 72 Yes Fluid trials SAFE (saline / 4% albumin) 59 No VISEP (starch / Ringer's) 64/65 No 6S (starch / Ringer's) 66/67 No ALBIOS (saline / 20% albumin ) 69/70 No SMART (saline / balanced fluid) 58 No Vasopressor trials SOAP II (NA vs DA) 67/68 No VASST (NA vs NA+AVP) 59/62 No CATS (NA vs ADR) 60/65 No MAP target SEPSISPAM 65 No Corticosteroids CORTICUS 63 No Adrenal 62/63 No

SEPTIC SHOCK - TREATMENT Cultures and antibiotics Fluids Vasopressors Corticosteroids Disposition decisions ward vs ICU.

CULTURES + ANTIBIOTICS Elderly higher rates of bacteraemia Gram negatives and multi-drug resistant organisms more likely Specific pathogens e.g. Listeria More likely to have ADR Blood cultures and informed AB choice therefore vital

CULTURES + ANTIBIOTICS Antibiotic treatment ASAP after blood cultures. Evidence for narrow time targets doubtful see:

RCT with intervention = prehospital CRO for sepsis CRO @ time = triage 26 mins ED AB @ time = triage + 70 mins Antibiotics 96 mins earlier had no difference on mortality for sepsis, severe sepsis, or shock.

CULTURES + ANTIBIOTICS Antibiotic treatment ASAP after blood cultures. Evidence for narrow time targets doubtful see: Narrow time to antibiotic targets will have consequences poor (no?) cultures and poor AB choice.

FLUIDS - VOLUME SSC guidelines: 30 ml/kg crystalloid, then bolus to targets Controversy regarding volume in sepsis Elderly more prone to side effects from excess volume is ventilation an option?

FLUIDS - TYPE Starch associated with renal dysfunction and mortality Hyperchloraemia associated with renal dysfunction and mortality

FLUIDS - TYPE ALBIOS provides some evidence for albumin

FLUID SUMMARY Err on side of less rather than more volume, titrate Avoid starch Avoid hyperchloraemia consider balanced fluids rather than reflex saline Consider albumin eg 20% albumin 100mL/hr X 3-4, +/- aim [ALB] >30 daily (Blood transfusion trigger in elderly sepsis is anybody s guess)

VASOPRESSORS Noradrenaline established 1 st line vasopressor, however unproven benefit. Consider NA trial via sturdy PIVC or venous vygon catheter Arginine vasopressin (AVP) may have role reduces NA requirements, constant dose. Terlipressin long-acting (intermittent dose) selective V1 > V2 agonist Selepressin highly selective V1 agonist, early trials promising.

STEROIDS Hydrocortisone 50mg q6h for presumed adrenal insufficiency (arguably more common in elderly) Annane, CORTICUS conflicting. Luckily we have ADRENAL (2018): 3800 patients with septic shock requiring invasive ventilation Mortality no difference However faster shock resolution, shorter ICU and hospital LOS

SOURCE CONTROL Removal of infected foreign bodies IDC, pacemaker, PIVC, CVAD Percutaneous drainage of collections: cholecystostomy, nephrostomy, ICC for empyema etc. Spinal anaesthesia may be an option

DISPOSITION Should I advocate for my elderly patient with septic shock to be admitted to ICU / retrieved? How can ward-based care be optimised?

DISPOSITION Should I advocate for my elderly patient with septic shock to be admitted to ICU / retrieved? Independent Good quality of life Urosepsis Heavily dependent Poor quality of life, unaware Non-urinary sepsis Substantial co-morbidity Respiratory failure with underlying lung disease Declines ICU Not determined to benefit * Consider benefits of ward-based care**

DISPOSITION Should I advocate for my elderly patient with septic shock to be admitted to ICU / retrieved? Independent Good quality of life Urosepsis Heavily dependent Poor quality of life Non-urinary sepsis Substantial co-morbidity Respiratory failure with underlying lung disease Declines ICU Not determined to benefit * Consider benefits of ward-based care**

DISPOSITION AGE MORTALITY RBWH Most ED patients hospitalised with septic shock are aged >65 Mortality increases linearly with age from (approx.) age 40 ICU admission rates drop sharply after age 70

SEPTIC SHOCK IN THE ELDERLY Conventional approach warranted antibiotics, fluids, vasopressors, source control Key discussions regarding ICU admission. There are advantages to ward-based care, which may be optimised.